167 related articles for article (PubMed ID: 35726770)
21. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
22. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study.
Zhu X; Zhou J; Zhou L; Zhang M; Gao C; Tao L
J Transl Med; 2022 Sep; 20(1):405. PubMed ID: 36064552
[TBL] [Abstract][Full Text] [Related]
23. Value of postoperative radiation therapy for regional control after dissection in head and neck squamous cell carcinoma cases.
Li XM; Di B; Shang YD; Tao ZF; Cheng JM; He ZG
Asian Pac J Cancer Prev; 2013; 14(7):4273-8. PubMed ID: 23991989
[TBL] [Abstract][Full Text] [Related]
24. What is the hold up?-Mixed-methods analysis of postoperative radiotherapy delay in head and neck cancer.
Sykes KJ; Morrow E; Smith JB; Holcomb AJ; TenNapel M; Lominska CE; Bur AM; Kakarala K
Head Neck; 2020 Oct; 42(10):2948-2957. PubMed ID: 33174308
[TBL] [Abstract][Full Text] [Related]
25. Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer.
Huo M; Panizza B; Bernard A; Porceddu SV
Oral Oncol; 2018 Feb; 77():43-48. PubMed ID: 29362125
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
27. Survival and disease progression following solitary locoregional recurrence after head and neck radiotherapy.
Zhao L; Day AT; Moon D; Avkshtol V; Sumer BD; Hughes R; Sher DJ
Head Neck; 2022 May; 44(5):1153-1163. PubMed ID: 35212070
[TBL] [Abstract][Full Text] [Related]
28. Post-operative therapy following transoral robotic surgery for unknown primary cancers of the head and neck.
Patel SA; Parvathaneni A; Parvathaneni U; Houlton JJ; Karni RJ; Liao JJ; Futran ND; Méndez E
Oral Oncol; 2017 Sep; 72():150-156. PubMed ID: 28797451
[TBL] [Abstract][Full Text] [Related]
29. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
Lee NCJ; Kelly JR; An Y; Park HS; Judson BL; Burtness BA; Husain ZA
Cancer; 2019 Jun; 125(12):2018-2026. PubMed ID: 30748002
[TBL] [Abstract][Full Text] [Related]
30. Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.
Schmitz S; Machiels JP; Weynand B; Gregoire V; Hamoir M
Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):437-43. PubMed ID: 18648835
[TBL] [Abstract][Full Text] [Related]
31. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
32. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy.
Dinshaw KA; Agarwal JP; Laskar SG; Gupta T; Shrivastava SK; Cruz AD
J Surg Oncol; 2005 Jul; 91(1):48-55. PubMed ID: 15999358
[TBL] [Abstract][Full Text] [Related]
33. Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
Jin MC; Harris JP; Sabolch AN; Gensheimer M; Le QT; Beadle BM; Pollom EL
Laryngoscope; 2020 Nov; 130(11):E598-E604. PubMed ID: 31837165
[TBL] [Abstract][Full Text] [Related]
34. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer.
Graboyes EM; Halbert CH; Li H; Warren GW; Alberg AJ; Calhoun EA; Nussenbaum B; Marsh CH; McCay J; Day TA; Kaczmar JM; Sharma AK; Neskey DM; Sterba KR
JCO Oncol Pract; 2020 Dec; 16(12):e1417-e1432. PubMed ID: 32853120
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
[TBL] [Abstract][Full Text] [Related]
36. Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
Ye AY; Hay JH; Laskin JJ; Wu JS; Ho CC
J Cancer Res Ther; 2013; 9(4):607-12. PubMed ID: 24518704
[TBL] [Abstract][Full Text] [Related]
37. Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy.
Fu X; Chen S; Chen W; Yang Z; Song M; Li H; Zhang H; Yao F; Su X; Liu T; Yang AK
Oral Oncol; 2018 Sep; 84():20-24. PubMed ID: 30115471
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
39. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
[TBL] [Abstract][Full Text] [Related]
40. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
